Literature DB >> 11058904

Novel splicing and missense mutations in autosomal dominant polycystic kidney disease 1 (PKD1) gene: expression of mutated genes.

G Aguiari1, S Savelli, M Garbo, A Bozza, G Augello, L Penolazzi, E De Paoli Vitali, C La Torre, G Cappelli, R Piva, L del Senno.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a common disorder mostly characterized by cyst formation in kidney tubules. The majority of ADPKD cases is caused by mutations in the PKD1 gene, but no prevalent mutation has been reported. By heteroduplex analysis of the 3' single-copy region of the gene, we have searched for mutations in subjects from 40 ADPKD families of Northern Italy. Seven novel polymorphisms and three novel disease-associated mutations (R3718Q, L3851P and IVS45+56del25) were identified. Both missense mutations are located in the major extracellular loop of polycystin-1. The 25 bp deletion inside intron 45 did not affect 5' and 3' consensus splicing sites, but caused a 56 nucleotide out of frame-deletion due to activation of a cryptic 3' splice site in exon 46. The mutated RNA should produce a truncated polycystin 1 at the G binding peptide in the intracellular C-terminal end of the protein. RT-PCR analysis showed that the disease-associated mutations were present in transcribed sequences. In particular, RNA analysis of BHK cells transfected with PKD1 genomic DNA, including the deleted intron, showed that no normal transcript is produced by the deleted gene. This intronic mutation, found in a large pedigree, seems to be associated with a prevalence of cerebrovascular disease. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11058904     DOI: 10.1002/1098-1004(200011)16:5<444::AID-HUMU11>3.0.CO;2-C

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  4 in total

1.  Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease.

Authors:  Miguel A Garcia-Gonzalez; Jeffrey G Jones; Susan K Allen; Christopher M Palatucci; Sat D Batish; William K Seltzer; Zheng Lan; Erica Allen; Feng Qian; Xose M Lens; York Pei; Gregory G Germino; Terry J Watnick
Journal:  Mol Genet Metab       Date:  2007-06-18       Impact factor: 4.797

2.  High Resolution Melt analysis for mutation screening in PKD1 and PKD2.

Authors:  Stanislas Bataille; Yvon Berland; Michel Fontes; Stéphane Burtey
Journal:  BMC Nephrol       Date:  2011-10-18       Impact factor: 2.388

3.  Biogenesis of mammalian microRNAs by a non-canonical processing pathway.

Authors:  Mallory A Havens; Ashley A Reich; Dominik M Duelli; Michelle L Hastings
Journal:  Nucleic Acids Res       Date:  2012-01-23       Impact factor: 16.971

4.  New mutations in the PKD1 gene in Czech population with autosomal dominant polycystic kidney disease.

Authors:  Jitka Stekrova; Jana Reiterova; Stanislava Svobodova; Vera Kebrdlova; Petr Lnenicka; Miroslav Merta; Ondrej Viklicky; Milada Kohoutova
Journal:  BMC Med Genet       Date:  2009-08-17       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.